The treatment of choice for CDI is the administration of synthetic ADH, also known as desmopressin or DDAVP. DDAVP is a synthetic analog of the endogenous hormone ADH, but with a 2,000-3,000 fold lower antidiuretic effect. The gene discussed is AVP; the disease is clostridium difficile infection.